REGiMMUNE Closed Second Tranche of Private Placement
Second Tranche of Private Placement Announced REGiMMUNE announced the closing [...]
Second Tranche of Private Placement Announced REGiMMUNE announced the closing [...]
REGiMMUNE Corporation announced today that it has appointed Mr. Kohtaro [...]
Tokyo, Japan – January 31, 2012 (US time)– REGiMMUNE Corporation [...]
Basis patent for the target specific tolerance induction by GalCer [...]
REGiMMUNE Corp. Announces Publication of preclinical GvHD data Tokyo, JAPAN–(Nov [...]
REGiMMUNE Presents New ToleroVax Data at the 2010 American Transplant [...]
About Press release from RIKEN regarding RGI-1001
Tokyo, Japan –Sep. 1, 2006 – REGiMMUNE Corporation, a privately [...]
KRN7000, a synthetic derivative of alpha-galactosylceramide, is a small molecule [...]
Tokyo, Japan and Mountain View, CA – July 22, 2009 – [...]